MACH32 INC.
$150,000.00 CAD
≈ 23 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2019-2020
- Agreement period
- November 14, 2019 – March 31, 2021
- Reference
- nrc-cnrc:172-2019-2020-Q3-939496
Published purpose
The objective of the proposed project is to further develop medication delivery system of SAVIOR™ medical device into a prototype model ready for testing, from TR3 to TRL6. The next step of development is to bench test the device components and then combine them into a complete prototype with several iterations of improvement and refinement. Ultimate goal is to advance development of SAVIOR™ for safe, quick and simple auto injection of medication Tranexamic Acid (TXA) in field settings to save lives of people suffering from massive trauma including bleeding.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 3, 2026 from open.canada.ca Grants & Contributions